Announcement
03 Oct 2023
In October 2023, US BARDA awarded a contract to Vir Biotechnology Inc to support the development of mRNA-expressed monoclonal antibodies.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
03 Oct 2023
Revocation date:
No revocation date
Updated: 03 Oct 2023
State aid, unspecified
In force
On 3 October 2023, the Biomedical Advanced Research and Development Authority (BARDA) of the United States announced awarding Vir Biotechnology Inc a contract to support the development of mRNA-exp...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.